Ozlem BULUT, Ihsan GURSEL

6328

Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection

Discovery of novel and broad-acting immunomodulators is of critical importance for the prevention and treatment of disorders occurring due to overexuberant immune responseincluding SARS-CoV-2 triggered cytokine storm leading to lung pathology and mortality during the ongoing viral pandemic. Mesenchymal stem/stromal cells (MSCs), highly regarded for their regenerative capacities, also possessesremarkable immunoregulatory functions affecting all types of innate and adaptive immune cells. Owing to that, MSCs have been heavily investigated in clinic for the treatment of autoimmune and inflammatory diseases along with transplant rejection. Extensive research in the last decaderevealed that MSCs carry out most of their functions through paracrine factors which are soluble mediators and extracellular vesicles (EVs). EVs, including exosomes and microvesicles, are an efficient way of intercellular communication due to their unique ability to carry biological messages such as transcription factors, growth factors, cytokines, mRNAs and miRNAs over long distances. EVs originate through direct budding of the cell membrane or the endosomal secretion pathway and they consist of the cytosolic and membrane components of their parent cell. Therefore, they are able to mimic the characteristics of the parent cell, affecting the target cells upon binding or internalization. EVs secreted by MSCs are emerging as a cell-free alternative to MSC-based therapies. MSC EVs are being tested in preclinical and clinical settings where they exhibit exceptional immunosuppressivecapacity. They regulate the migration, proliferation, activation and polarization of various immune cells, promoting a tolerogenic immune response while inhibiting inflammatory response. Being as effective immunomodulators as their parent cells, MSC EVs are also preferable over MSC-based therapies due to their lower risk of immunogenicity, tumorigenicity and overall superior safety. In this review, we present the outcomes of preclinical and clinical studies utilizing MSC EVs as therapeutic agents for the treatment of a wide variety of immunological disorders.
Keywords:

Mesenchymal stem cells, extracellular vesicles, exosomes, inflammation autoimmunity, COVID-19,

PDF

___

  • Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
  • Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002
  • Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979
  • Bai LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04559-y
  • Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
  • Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5
  • Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207
  • Brown JM, 2011, CLIN EXP ALLERGY, V41, P526, DOI 10.1111/j.1365-2222.2010.03685.x
  • Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
  • Chatterjee D, 2014, BLOOD, V123, P594, DOI 10.1182/blood-2013-09-524827
  • Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
  • Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135
  • Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353
  • Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841
  • Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657
  • Cosenza S, 2018, THERANOSTICS, V8, P1399, DOI 10.7150/thno.21072
  • CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5
  • Crop MJ, 2010, CLIN EXP IMMUNOL, V162, P474, DOI 10.1111/j.1365-2249.2010.04256.x
  • Deng YA, 2014, STEM CELLS DEV, V23, P2080, DOI 10.1089/scd.2013.0559
  • Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
  • Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X
  • Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
  • El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]
  • Figliuzzi Marina, 2014, World J Stem Cells, V6, P163, DOI 10.4252/wjsc.v6.i2.163
  • Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021
  • Franquesa M, 2015, STEM CELLS, V33, P880, DOI 10.1002/stem.1881
  • FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
  • Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696
  • Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
  • Hoffmann M., 2020, BIORXIV, DOI [10.1101/2020.01.31.929042., DOI 10.1101/2020.01.31.929042]
  • Jiang DS, 2016, STEM CELLS, V34, P2393, DOI 10.1002/stem.2417
  • Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029
  • Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248
  • Kim HS, 2017, STEM CELLS, V35, P248, DOI 10.1002/stem.2401
  • Kim HS, 2015, STEM CELLS, V33, P1254, DOI 10.1002/stem.1913
  • Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41
  • Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003
  • LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
  • Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173
  • Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228
  • Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395
  • Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821
  • Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717
  • Liu XX, 2012, J IMMUNOL, V189, P1182, DOI 10.4049/jimmunol.1102996
  • Luz-Crawford P, 2016, STEM CELLS, V34, P483, DOI 10.1002/stem.2254
  • Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216
  • Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003
  • Mao F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5356760
  • Marrazzo P, 2019, J MOL MED, V97, P437, DOI 10.1007/s00109-019-01752-6
  • Melief SM, 2013, STEM CELL TRANSL MED, V2, P455, DOI 10.5966/sctm.2012-0184
  • Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010
  • Nassar Wael, 2016, Biomater Res, V20, P21, DOI 10.1186/s40824-016-0068-0
  • Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
  • Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260
  • Pan GH, 2016, ONCOTARGET, V7, P12089, DOI 10.18632/oncotarget.7725
  • Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
  • Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871
  • Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
  • Schena F, 2010, ARTHRITIS RHEUM-US, V62, P2776, DOI 10.1002/art.27560
  • Selleri S, 2016, ONCOTARGET, V7, P30193, DOI 10.18632/oncotarget.8623
  • Shen B, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1240301
  • Shigemoto-Kuroda T, 2017, STEM CELL REP, V8, P1214, DOI 10.1016/j.stemcr.2017.04.008
  • Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963
  • Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997
  • Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943
  • Stahl PD, 2019, PHYSIOLOGY, V34, P169, DOI 10.1152/physiol.00045.2018
  • Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149
  • Sun GD, 2018, MAT SCI ENG C-MATER, V89, P194, DOI 10.1016/j.msec.2018.04.006
  • Tabera S, 2008, HAEMATOL-HEMATOL J, V93, P1301, DOI 10.3324/haematol.12857
  • Tamura R, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0030-5
  • Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316
  • Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594
  • Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052
  • Wang BY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0463-4
  • Wang DD, 2013, CELL TRANSPLANT, V22, P2267, DOI [10.3727/096368911X582769c, 10.3727/096368911X582769]
  • Wang L, 2016, STEM CELLS DEV, V25, P1874, DOI 10.1089/scd.2016.0107
  • Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
  • Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521
  • Willis GR, 2018, AM J RESP CRIT CARE, V197, P104, DOI 10.1164/rccm.201705-0925OC
  • Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066
  • Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140551
  • Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002
  • Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138
  • Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503
  • Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190
  • Zhang ZW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002856
  • Zhao H, 2018, DIABETES, V67, P235, DOI 10.2337/db17-0356
  • Zhao K, 2015, BIOL BLOOD MARROW TR, V21, P97, DOI 10.1016/j.bbmt.2014.09.030
  • Zhao RCH, 2020, STEM CELLS DEV, V29, P679, DOI 10.1089/scd.2020.0071
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Ogun ADEBALİ, Aylin BİRCAN, Defne CİRCİ, Burak ISLEK, Zeynep KİLİNC, Berkay SELCUK, Berk TURHAN

Erman Salih ISTİFLİ, Arzuhan Sihoglu TEPE, Cengiz SARİKURKCU, Bektas TEPE

Ozlem BULUT, Ihsan GURSEL

Osman Mutluhan UGUREL, Oguz ATA, Dilek TURGUT-BALİK

Busra AKTAS, Belma ASLIM

Cihan TASTAN, Bulut YURTSEVER, Gozde Sir KARAKUS, Derya Dilek KANCAGİ, Sevda DEMİR, Selen ABANUZ, Utku SEYİS, Mulazim YİLDİRİM, Recai KUZAY, Omer ELİBOL, Serap ARBAK, Merve Acikel ELMAS, Selcuk BİRDOGAN, Osman Ugur SEZERMAN, Aye Sesin KOCAGOZ, Koray YALCİN, Ercument OVALİ

Ayse Banu DEMİR, Domenico BENVENUTO, Hakan ABACİOGLU, Silvia ANGELETTİ, Massimo CİCCOZZİ

Tauseef AHMAD, Haroon HAROON, Kuldecip DHAMA, Khan SHARUN, Fazal Mehmood KHAN, Irfan AHMED, Ruchi TİWARİ, Taha Hussien MUSA, Muhammad KHAN, D. Katterine BONİLLA-ALDANA, Alfonso J. RODRİGUEZ-MORALES, Jin HUİ

Aftab ALAM, Mohd Faizan SİDDİQUİ, Nikhat IMAM, Rafat ALİ, Md MUSHTAQUE, Romana ISHRAT

Serdar DURDAGİ